Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Mangoceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 5 | 9 | +4 |
| Shares | 91.0K | 127.5K | +36.5K (+40.1%) |
| Value | $166.4K | $135.8K | −$30.7K (−18.4%) |
New holders (7)
Institutions that held Mangoceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 47,176 | $41.5K | 0.00% |
| Desjardins Global Asset Management Inc. | 127 | $25.1K | 0.00% |
| Vanguard Capital Wealth Advisors | 25,000 | $21.3K | 0.02% |
| Virtu Financial LLC | 23,482 | $21.0K | 0.00% |
| McCollum Christoferson Group LLC | 11,300 | $9.61K | 0.00% |
| Private Advisor Group, LLC | 10,200 | $8.68K | 0.00% |
| Bank of America Corp | 120 | $102 | 0.00% |
Sold out (3)
Institutions that held Mangoceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Colonial River Wealth Management, LLC | 36,100 | $66.1K |
| Two Sigma Investments, LP | 27,103 | $49.6K |
| Private Trust Co NA | 1,500 | $2.75K |